CDK1 and neoplasm: Both these series of compounds showed antiproliferative activity against a wide range of human tumor cell lines in the micromolar-submicromolar range and were able to inhibit the activity of the cyclin-dependent kinase 1 (CDK1) with GI50 values lower than 1 μM [41,42].